Localization of LRRK2 to membranous and vesicular structures in mammalian brain

Annals of Neurology

Volumn 60, Issue 5, 2006, Pages 557-569

  Biskup, Saskia ^a   Moore, Darren J ^a   Celsi, Fulvio ^b   Higashi, Shinji ^c,d   West, Andrew B ^a   Andrabi, Shaida A ^a   Kurkinen, Kaisa ^a   Yu, Seong Woon ^a   Savitt, Joseph M ^a   Waldvogel, Henry J ^e   Faull, Richard L M ^e   Emson, Piers C ^d   Torp, Reidun ^b   Ottersen, Ole P ^b   Dawson, Ted M ^a   Dawson, Valina L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c JUNTENDO UNIVERSITY   (Japan)

^d BABRAHAM INSTITUTE   (United Kingdom)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; LEUCINE RICH REPEAT KINASE 2; LIPID; LIPID BINDING PROTEIN; POLYCLONAL ANTIBODY;

ADULT; AGED; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BASAL GANGLION; BINDING AFFINITY; BRAIN CELL; BRAIN MITOCHONDRION; BRAIN NERVE CELL; BRAIN SYNAPTOSOME; CARBOXY TERMINAL SEQUENCE; CELL FRACTIONATION; CELL LABELING; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; DENDRITE; ENDOSOME; GENE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYSOSOME; MAMMAL CELL; MEMBRANE STRUCTURE; MEMBRANE VESICLE; MICROSOME; MOUSE; NERVE FIBER; NONHUMAN; ONSET AGE; PARK8 GENE; PARKINSON DISEASE; PERIKARYON; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; RAT; SYNAPSE VESICLE; TRANSPORT VESICLE; WESTERN BLOTTING;

ANIMALS; ANTIBODY AFFINITY; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; BRAIN; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEURONS; PROTEIN-SERINE-THREONINE KINASES; R-SNARE PROTEINS; RATS; SUBCELLULAR FRACTIONS;

EID: 33845298032     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21019     Document Type: Article

References (23)

1. Funayama M, Hasegawa K, Kowa H, et al. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002;51:296-301.
2. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
3. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
4. Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 2005;28:57-87.
5. West AB, Moore DJ, Biskup S, et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 2005;102:16842-16847.
6. Bosgraaf L, Van Haastert PJ. Roc, a Ras/GTPase domain in complex proteins. Biochim Biophys Acta 2003;1643:5-10.
7. Korr D, Toschi L, Donner P, et al. LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain. Cell Signal 2006;18:910-920.
8. Gloeckner CJ, Kinkl N, Schumacher A, et al. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 2006;15:223-232.
9. Moore DJ, Zhang L, Dawson TM, Dawson VL. A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homooligomerization. J Neurochem 2003;87:1558-1567.
10. Chung KK, Zhang Y, Lim KL, et al. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 2001;7:1144-1150.
11. Zhang L, Shimoji M, Thomas B, et al. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet 2005;14:2063-2073.
12. Pevsner J, Hsu SC, Braun JE, et al. Specificity and regulation of a synaptic vesicle docking complex. Neuron 1994;13:353-361.
13. Dawson VL, Dawson TM, Bartley DA, et al. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-2661.
14. Moore D, Chambers J, Waldvogel H, et al. Regional and cellular distribution of the P2Y(1) purinergic receptor in the human brain: striking neuronal localisation. J Comp Neurol 2000;421:374-384.
15. Takumi Y, Ramirez-Leon V, Laake P, et al. Diffetent modes of expression of AMPA and NMDA receptors in hippocampal synapses. Nat Neurosci 1999;2:618-624.
16. Galter D, Westerlund M, Carmine A, et al. LRRK2 expression linked to dopamine-innervated areas. Ann Neurol 2006;59:714-719.
17. Simon-Sanchez J, Herranz-Perez V, Olucha-Bordonau F, Perez-Tur J. LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain. Eur J Neurosci 2006;23:659-666.
18. Li C, Beal MF. Leucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis. Proc Natl Acad Sci U S A 2005;102:16535-16536.
19. Naylor K, Ingerman E, Okreglak V, et al. Mdv1 interacts with assembled dnm1 to promote mitochondrial division. J Biol Chem 2006;281:2177-2183.
20. Uemura K, Kuzuya A, Shimohama S. Protein trafficking and Alzheimer's disease. Curr Alzheimer Res 2004;1:1-10.
21. Smith R, Brundin P, Li JY. Synaptic dysfunction in Huntington's disease: a new perspective. Cell Mol Life Sci 2005;62:1901-1912.
22. Hauser MA, Li YJ, Xu H, et al. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch Neurol 2005;62:917-921.
23. Sakaguchi A, Hisamota N, Jin Y, Matsumoto K. C. elegans lrk-1 MAPKKK regulates synaptic vesicle transport. East Asia Worm Meeting, 2004. Awaji Island, Japan.